Growing Number Of Clinical Trials Fuels Cell And Gene Therapy Market Growth Is Supporting Development Across The Cell and Gene Therapy Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Will Be The Estimated Market Size Of The Cell and Gene Therapy Market By 2030?

The market for cell and gene therapy has witnessed significant expansion over recent years. It is projected to grow from $21.33 billion in 2025 to $26.21 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.9%. Historically, this growth can be attributed to factors such as the limited availability of cell and gene therapies, reliance on conventional treatment modalities, the high cost of early-generation therapies, the growing incidence of oncology and neurological disorders, and a lack of specialized treatment centers.

The cell and gene therapy market size is anticipated to experience substantial growth in the upcoming years. It is predicted to expand to $60.58 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 23.3%. This expansion over the forecast period can be attributed to the progression of advanced CAR-T and genome editing therapies, an increase in clinical trials and research programs, the growing embrace of personalized medicine, enhanced government support and funding for rare disease treatments, and the incorporation of digital platforms for therapy monitoring and patient management. Significant trends during this period are expected to involve the increased adoption of CAR-T and stem cell therapies, a rise in investment for gene therapy in oncology and rare diseases, the development of personalized and targeted cell-based treatments, the expansion of hospitals and ambulatory surgical centers providing advanced therapies, and the integration of genome editing and viral vector-based technologies into clinical practice.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3472&type=smp

What Important Drivers Are Powering The Cell and Gene Therapy Market Growth?

The increasing number of ongoing clinical trials is projected to fuel the expansion of the cell and gene therapy market moving forward. Clinical trials are investigative studies carried out with human participants to determine the safety and effectiveness of novel medical treatments, interventions, or diagnostic methods. These trials are fundamental to the progress and development of cell and gene therapy, offering a secure and regulated environment to test new therapies and acquire data concerning their safety and efficacy. For example, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based entity, indicated that the quantity of pharmaceutical industry trials initiated in the UK grew for the second successive year, climbing from 411 in 2022 to 426 in 2023. Thus, a rising volume of active clinical trials is stimulating the growth of the cell and gene therapy market.

How Is The Cell and Gene Therapy Market Examined Through Segment Analysis?

The cell and gene therapy market covered in this report is segmented –

1) By Product: Cell Therapy, Gene Therapy

2) By Application: Oncology, Neurological Disorders, Other Applications

3) By End User: Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users

Subsegments:

1) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, CAR-T Cell Therapy

2) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Genome Editing Technologies, Antisense Oligonucleotide Therapy

Which Trends Are Shaping The Cell and Gene Therapy Market Landscape?

Leading companies in the cell and gene therapy market are intensifying their efforts to introduce agnostic systems, aiming to secure a competitive advantage. Agnostic systems are defined as those capable of integrating with various cell and gene therapy (CGT) software platforms, alongside biopharmaceutical or provider-facing platforms. For example, in April 2023, AmerisourceBergen, a US-based healthcare company, unveiled the Cell and Gene Therapy Integration Hub. This novel platform-agnostic system seeks to enhance connectivity throughout the cell and gene therapy (CGT) treatment journey, thereby improving the patient and provider experience. The hub operates using the company’s customer relationship management system and is built to accelerate the benefits investigation process, provide real-time visibility into therapy development and transportation status, and aid in coordinating patient support.

Which Firms Are Competing In The Cell and Gene Therapy Market?

Major companies operating in the cell and gene therapy market are Biogen Inc., Novartis AG, Gilead Sciences, Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., ArrowHead Pharmaceuticals Inc., Spark Therapeutics, Bluebird Bio Inc., RegenexBio, Mesoblast Limited, Stempeutics Research Pvt. Ltd., EdiGene Inc., Takara Bio, Oxford Biomedica plc, Merck, GenScript, Cellular Biomedicine Group, inStem, Bristol-Myers Squibb, Amgen, Pfizer, Kite Pharma, Freeline Therapeutics, PsiOxus Therapeutics, Herantis Pharma Plc, AstraZeneca

Access The Complete Cell and Gene Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

Which Geographic Region Represents The Largest Cell and Gene Therapy Market Share?

North America was the largest region in the cell and gene therapy market in 2025. The regions covered in the cell and gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Cell and Gene Therapy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=3472&type=smp

Browse Through More Reports Similar to the Global Cell and Gene Therapy Market 2026, By The Business Research Company

Cancer Biologics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Nucleic Acid Based Gene Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Genes Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795